The BCW Index has started the second half of 2006 strongly with a gain of 3.4 percent for the shortened trading week ended Monday. The Nasdaq Biotech Index outpaced the BCW Index, climbing 5.2 percent, while the Nasdaq gained 4.3 percent, and the Dow Jones Industrial Average rose 2.8 percent. Every stock in the Index gained ground for the tracking period, with Stratagene leading the way with a rise of 12.7 percent. Qiagen and Fisher Scientific both rose more than 6 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.